Bioactivity | PF-04822163 is an orally active, selective, and blood-brain barrier permeable PDE1 inhibitor with IC50 values of 2 nM, 2.4 nM, and 7 nM for PDE1A, PDE1B, and PDE1C respectively. PF-04822163 can be used in the research of attention deficit hyperactivity disorder or Parkinson's disease[1]. |
In Vivo | PF-04822163 (10 mg/kg; 口服; 单剂量) 在 0.5 h 时大鼠血浆中的 Tmax 为 274 ng/mL,终末半衰期为 5.5 h,且具有血脑屏障透过性[1]。在大鼠药代动力学分析[1]species |
CAS | 1798334-07-2 |
Formula | C19H17ClN2O2 |
Molar Mass | 340.80 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Humphrey J M, et al. Small-molecule phosphodiesterase probes: discovery of potent and selective CNS-penetrable quinazoline inhibitors of PDE1[J]. MedChemComm, 2014, 5(9): 1290-1296. |